… cells producing antibodies to human immunodeficiency virus (… B cells with Epstein-Barr virus.
Mononuclear cells from 58 HIV-… been stable with respect to antibody production for up to 15 …

… antibodies that are group specific and capable of neutralizing all isolates of HIV-1. However,
in this study, we used a panel of human monoclonal antibodies … monoclonal antibody to the …

… monoclonal antibodies after … monoclonal antibodies protect against mucosal lentivirus
challenge in neonates. We conclude that epitopes recognized by the three monoclonal antibodies …

… Broadly neutralizing monoclonal antibodies (MAbs) are potentially important tools in
human immunodeficiency virus type 1 (HIV-1) vaccine design. A few rare MAbs have been …

… envelope proteins of human immunodeficiency virus type 1 (HIV-1) is essential for both
the design of a vaccine and the preparation of polyclonal and/or monoclonal antibodies (MAbs) …

… We have isolated and characterized human monoclonal antibody 2G12 to the gp120 surface
glycoprotein of human immunodeficiency virus type 1 (HIV-1). This antibody potently and …

… and oligomeric gpI20 glycoproteins from the LAI isolate of human immunodeficiency virus
type 1 (HIV-1) with a panel of monoclonal antibodies (MAbs); most of these MAbs are directed …

… Passive immunization with broadly neutralizing antibodies (bnAbs) is a promising approach
to reduce the 1.7 million annual human immunodeficiency virus (HIV) infections globally. …

… A monoclonal antibody was produced to the exterior envelope glycoprotein (gpl20) of the
human T-cell lymphotropic virus … In this report, we describe a monoclonal antibody produced by …

… relevant strains of human immunodeficiency virus type 1 (HIV-… to date has examined whether
monoclonal antibodies, small … PRO 140 (PA14) is an anti-CCR5 monoclonal antibody that …